Association of Salivary Amino Acid With Oral Squamous Cell Carcinoma Identified by Liquid Chromatography Mass Spectroscopy

Status: Unknown
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Oral Squamous Cell Carcinoma (OSCC) is the most common oral malignancy worldwide. The prognosis of the OSCC patient is not significant despite the modern treatment facilities. Late presentation is one of the most crucial cause of this and for that reason, the importance of early diagnosis of OSCC should be the main concern. Till now, incisional biopsy followed by histopathological examination is the gold standard for diagnosis of oral cancer. The aim of the present study is to find out the association of salivary amino acid levels with oral squamous cell carcinoma, whether the levels are increased or decreased in the patient suffering from OSCC. This might be helpful for early diagnosis of oral cancer and better prognosis.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Age: 18-70 years.

• Both genders.

• Patient with histo-pathologically diagnosedoral squamous carcinoma

• Willing to participate in the study. Inclusion criteria for controls

• Healthy patients without any malignancy

• Patients relatively almost the same age group of cases

Locations
Other Locations
Bangladesh
Bangabandhu Sheikh Mujib Medical University (BSMMU)
RECRUITING
Dhaka
Bangladesh Reference Institute for Chemical Measurements
RECRUITING
Dhaka
Contact Information
Primary
Mala Khan, Dr.
malakhan_07@yahoo.com
+8801715032057
Backup
Dr. Mahmuda Akhter, Asst. Prof.
mahmudanaz@gmail.com
+8801713063778
Time Frame
Start Date: 2020-12-15
Completion Date: 2022-03-30
Participants
Target number of participants: 110
Treatments
Patients with Progressive Disease and without Progressive Disease
1. Patients with Progressive Disease Patients with metastasis and/or recurrent OSCC were considered as a group of subjects with progressive disease.~2. Patients with without Progressive Disease Patients without metastasis and/or recurrent OSCC were considered as a group of subjects without progressive disease.
Related Therapeutic Areas
Sponsors
Leads: DR. MALA KHAN
Collaborators: Bangladesh Reference Institute of Chemical Measurements (BRICM)

This content was sourced from clinicaltrials.gov